At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism
In Brief
A Phase 4 clinical trial evaluating Testosterone gel 1.62% and Placebo for Type 2 Diabetes Mellitus and Hypogonadism. Completed, enrolled 92 participants across 1 site.
Detailed Summary
Low testosterone and diabetes mellitus are each associated with increased risk for fractures. Men with diabetes mellitus are commonly found to have low testosterone as well. Testosterone has been shown to improve the bone health of patients with low testosterone but has not been tested in patients who also have diabetes mellitus in addition to low testosterone. To date, there is no treatment that is specifically recommended for bone disease among patients with diabetes. This study will evaluate the effect of testosterone on the bone health of male Veterans who have both diabetes and low testosterone, both of which are highly prevalent in this subset of the population.
Study Details
Timeline
Interventions
Testosterone gel 1.62%, apply 2 pumps to upper arm and shoulder.
Matching placebo gel, apply 2 pumps to upper arm and shoulder